NGM
Point72 Asset Management’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-23,116
| Closed | -$94.3K | – | 2293 |
|
|
2023
Q1 | $94.3K | Buy |
+23,116
| New | +$94.3K | ﹤0.01% | 1154 |
|
|
2022
Q4 | – | Sell |
-362,900
| Closed | -$4.75M | – | 1476 |
|
|
2022
Q3 | $4.75M | Sell |
362,900
-957,762
| -73% | -$12.5M | 0.02% | 646 |
|
|
2022
Q2 | $16.9M | Sell |
1,320,662
-1,890,209
| -59% | -$24.2M | 0.07% | 334 |
|
|
2022
Q1 | $49M | Sell |
3,210,871
-87,027
| -3% | -$1.33M | 0.19% | 137 |
|
|
2021
Q4 | $58.4M | Buy |
3,297,898
+1,854,904
| +129% | +$32.9M | 0.23% | 104 |
|
|
2021
Q3 | $30.3M | Buy |
1,442,994
+578,794
| +67% | +$12.2M | 0.13% | 200 |
|
|
2021
Q2 | $17M | Sell |
864,200
-1,310,800
| -60% | -$25.8M | 0.08% | 305 |
|
|
2021
Q1 | $63.2M | Buy |
2,175,000
+413,843
| +23% | +$12M | 0.3% | 72 |
|
|
2020
Q4 | $53.4M | Buy |
1,761,157
+149,307
| +9% | +$4.52M | 0.26% | 82 |
|
|
2020
Q3 | $25.6M | Buy |
1,611,850
+88,265
| +6% | +$1.4M | 0.13% | 206 |
|
|
2020
Q2 | $30.1M | Buy |
1,523,585
+527,290
| +53% | +$10.4M | 0.2% | 143 |
|
|
2020
Q1 | $12.3M | Buy |
+996,295
| New | +$12.3M | 0.1% | 276 |
|